Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information.
about
Increased cytoplasmic level of migfilin is associated with higher grades of human leiomyosarcomaTumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcomeADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperonesMolecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosisPredicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis.Alpha-catenin expression is decreased in patients with gastric carcinomaMolecular pathways in bladder cancer: part 2.CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor.Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program.Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition.The role of the beta1 subunit of the Na,K-ATPase and its glycosylation in cell-cell adhesion.Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis.Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?
P2860
Q24647992-765F5CF9-B56C-4763-8EBC-2D41E3A0DBF3Q28201662-A6466EB0-4859-4458-9BC6-0D0849FC6165Q28476496-E6BA25F5-2DCD-47BC-BC2A-0305CCACCE52Q30439612-62D54A50-AF02-4906-BA4A-581E99985A68Q30446429-C3849BA5-F075-4ABD-B235-92397E7B22FAQ35045405-2A65FD07-627A-40C0-A83E-65B23E9BA9DCQ36037512-C1D8AE1B-2A0F-470D-B4D0-963052729AA2Q36272100-AEE34E67-05B4-46C3-8966-DAAFAA2B4CC2Q36589325-7FE52DC6-7CBC-4C74-AE51-7A09A4181EA2Q39327058-BEE6A9FD-6864-461C-9ECC-EFF608273E18Q40217811-0C87771E-B9D6-41FF-9472-050D44AB9CDCQ42365349-D2B70E4A-82EA-4CE3-91A2-411BB6804E01Q43539828-E151FA2D-F1D9-458A-B23B-89706D278A91Q44039920-7126A955-42CA-4830-9F20-11BB9FB70C68Q46818029-7A19081F-6099-453C-B8A5-703B6D018F84Q53287829-E178B7E2-F89E-40DB-ADD2-EAD277620FCC
P2860
Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Low E-cadherin expression in b ...... ovides prognostic information.
@ast
Low E-cadherin expression in b ...... ovides prognostic information.
@en
type
label
Low E-cadherin expression in b ...... ovides prognostic information.
@ast
Low E-cadherin expression in b ...... ovides prognostic information.
@en
prefLabel
Low E-cadherin expression in b ...... ovides prognostic information.
@ast
Low E-cadherin expression in b ...... ovides prognostic information.
@en
P2093
P2860
P356
P1476
Low E-cadherin expression in b ...... ovides prognostic information.
@en
P2093
Bastuji-Garin S
Gil-Diez de Medina S
Lefrere-Belda MA
Radvanyi F
P2860
P2888
P304
P356
10.1054/BJOC.2000.1233
P407
P577
2000-07-01T00:00:00Z
P5875
P6179
1045178992